千金药业：国家药品监督管理局批准公司的补血益母丸为首家中药二级保护品种

Core Viewpoint - Qianjin Pharmaceutical (600479) has received approval from the National Medical Products Administration for its product, Bu Xue Yi Mu Wan, making it the first Chinese medicine to be classified as a secondary protected variety [1] Group 1 - The approved product, Bu Xue Yi Mu Wan, is indicated for conditions related to deficiency of both qi and blood, as well as blood stasis, particularly for postpartum abdominal pain [1]